Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
Authors
Keywords
CRISPR-Cas, Delivery, AAV, Virus-like particle, Lipid nanoparticle, Gene therapy
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 342, Issue -, Pages 345-361
Publisher
Elsevier BV
Online
2022-01-11
DOI
10.1016/j.jconrel.2022.01.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
- (2021) Di Yin et al. NATURE BIOTECHNOLOGY
- Identifying genome-wide off-target sites of CRISPR RNA–guided nucleases and deaminases with Digenome-seq
- (2021) Daesik Kim et al. Nature Protocols
- In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA
- (2021) Lukas Villiger et al. Nature Biomedical Engineering
- Engineered prime editors with PAM flexibility
- (2021) Jiyeon Kweon et al. MOLECULAR THERAPY
- Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
- (2021) Min Qiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Precise base editing for the in vivo study of developmental signaling and human pathologies in zebrafish
- (2021) Marion Rosello et al. eLife
- Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
- (2021) Saghi Nooraei et al. JOURNAL OF NANOBIOTECHNOLOGY
- Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein
- (2021) Akihiro Kagita et al. Stem Cell Reports
- Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
- (2021) Naoya Uchida et al. Molecular Therapy-Methods & Clinical Development
- Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
- (2021) James K. Nuñez et al. CELL
- Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain
- (2021) Saed Abbasi et al. JOURNAL OF CONTROLLED RELEASE
- In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
- (2021) Kiran Musunuru et al. NATURE
- In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
- (2021) Tanja Rothgangl et al. NATURE BIOTECHNOLOGY
- Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy
- (2021) Tzu-Chieh Ho et al. Science Advances
- Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
- (2021) Mohammadsharif Tabebordbar et al. CELL
- Prime editing – an update on the field
- (2021) Janine Scholefield et al. GENE THERAPY
- Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
- (2021) Despo Chatzikleanthous et al. MOLECULAR PHARMACEUTICS
- Detect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors
- (2021) Zhixin Lei et al. NATURE METHODS
- Transgenic mice for in vivo epigenome editing with CRISPR-based systems
- (2021) Matthew P. Gemberling et al. NATURE METHODS
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
- (2021) Julian D. Gillmore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient precise in vivo base editing in adult dystrophic mice
- (2021) Li Xu et al. Nature Communications
- Genetically blocking HPD via CRISPR-Cas9 protects against lethal liver injury in a pig model of tyrosinemia type I
- (2021) Peng Gu et al. Molecular Therapy-Methods & Clinical Development
- In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
- (2021) Matthew Behr et al. Acta Pharmaceutica Sinica B
- Efficient Peptide-Mediated In Vitro Delivery of Cas9 RNP
- (2021) Oskar Gustafsson et al. Pharmaceutics
- Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
- (2021) Eriya Kenjo et al. Nature Communications
- Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
- (2020) Ignazio Maggio et al. GENE THERAPY
- A primate view of gene expression
- (2020) Linda Koch NATURE REVIEWS GENETICS
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice
- (2020) Koji M. Nishiguchi et al. Nature Communications
- A mutation-independent CRISPR-Cas9–mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency
- (2020) Lili Wang et al. Science Advances
- Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
- (2020) Yu Zhang et al. Science Advances
- A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I
- (2020) Li Ou et al. MOLECULAR THERAPY
- AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
- (2020) Ang Li et al. MOLECULAR THERAPY
- Correction of three prominent mutations in mouse and human models of Duchenne muscular dystrophy by single-cut genome editing
- (2020) Yi-Li Min et al. MOLECULAR THERAPY
- A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects
- (2020) Erwei Zuo et al. NATURE METHODS
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- Gene-editing pipeline takes off
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity
- (2020) Yi Yu et al. Nature Communications
- Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
- (2020) Peter Gee et al. Nature Communications
- Recent Advances in CRISPR/Cas9 Delivery Strategies
- (2020) Bon Ham Yip Biomolecules
- Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
- (2020) Young Hun Chung et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
- (2020) Tuo Wei et al. Nature Communications
- Germline CRISPR/Cas9-Mediated Gene Editing Prevents Vision Loss in a Novel Mouse Model of Aniridia
- (2020) Seyedeh Zeinab Mirjalili Mohanna et al. Molecular Therapy-Methods & Clinical Development
- Non-viral Gene Disruption by CRISPR/Cas9 Delivery Using Cell-permeable and Protein-stabilizing 30Kc19 Protein
- (2020) Yu Jin Kim et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Predicting the efficiency of prime editing guide RNAs in human cells
- (2020) Hui Kwon Kim et al. NATURE BIOTECHNOLOGY
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prime editing for functional repair in patient-derived disease models
- (2020) Imre F. Schene et al. Nature Communications
- Delivery Approaches for Therapeutic Genome Editing and Challenges
- (2020) Ilayda Ates et al. Genes
- A Cas-embedding strategy for minimizing off-target effects of DNA base editors
- (2020) Yajing Liu et al. Nature Communications
- Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition
- (2020) Yuichi Suzuki et al. JOURNAL OF CONTROLLED RELEASE
- Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
- (2019) Morgan L. Maeder et al. NATURE MEDICINE
- Genome-wide profiling of adenine base editor specificity by EndoV-seq
- (2019) Puping Liang et al. Nature Communications
- Engineering of CRISPR-Cas12b for human genome editing
- (2019) Jonathan Strecker et al. Nature Communications
- CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
- (2019) Yi-Li Min et al. Science Advances
- Engineering of high-precision base editors for site-specific single nucleotide replacement
- (2019) Junjie Tan et al. Nature Communications
- Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos
- (2019) Erwei Zuo et al. SCIENCE
- Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice
- (2019) Shuai Jin et al. SCIENCE
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- Genome-wide target specificity of CRISPR RNA-guided adenine base editors
- (2019) Daesik Kim et al. NATURE BIOTECHNOLOGY
- Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
- (2019) Justine Habault et al. MOLECULES
- Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9
- (2019) Calvin J. Stephens et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
- (2019) Huaigeng Xu et al. Cell Stem Cell
- Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
- (2019) Danny Wilbie et al. ACCOUNTS OF CHEMICAL RESEARCH
- Ultrasound microbubble-mediated CRISPR/Cas9 knockout of C-erbB-2 in HEC-1A cells
- (2019) Junhong Cai et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
- (2019) Shayesteh R. Ferdosi et al. Nature Communications
- Delivery of CRISPR/Cas9 for therapeutic genome editing
- (2019) Xiaojie Xu et al. JOURNAL OF GENE MEDICINE
- Molecular mechanisms of epigenetic inheritance: Possible evolutionary implications
- (2019) Peter Sarkies SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice
- (2019) Gaia Colasante et al. MOLECULAR THERAPY
- The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape
- (2019) Daniel N. Weinberg et al. NATURE
- CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
- (2019) Lei Xu et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia
- (2019) Huan Zhao et al. CIRCULATION
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- High levels of AAV vector integration into CRISPR-induced DNA breaks
- (2019) Killian S. Hanlon et al. Nature Communications
- In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse
- (2019) Leonela Amoasii et al. Nature Communications
- In vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk gene
- (2019) Cyril J. Peter et al. Nature Communications
- Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
- (2019) Jee-Yeon Ryu et al. BIOMATERIALS
- State‐of‐the‐art human adenovirus vectorology for therapeutic approaches
- (2019) Jian Gao et al. FEBS LETTERS
- The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model
- (2019) Weisong Duan et al. GENE THERAPY
- Gene therapy for hemophilia
- (2019) Amit C. Nathwani Hematology-American Society of Hematology Education Program
- AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
- (2019) Daelyn Y. Richards et al. Molecular Therapy-Methods & Clinical Development
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity
- (2018) Nicole K. Paulk et al. MOLECULAR THERAPY
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- (2018) Taeyoung Koo et al. Nature Communications
- CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
- (2018) M. Charpentier et al. Nature Communications
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
- (2018) Claudia Montagna et al. Molecular Therapy-Nucleic Acids
- Virus-like particle vaccines: immunology and formulation for clinical translation
- (2018) Braeden Donaldson et al. Expert Review of Vaccines
- Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus
- (2018) Lee A. Campbell et al. MOLECULAR THERAPY
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- Viral vector-based delivery of CRISPR/Cas9 and donor DNA for homology directed repair in an in vitro model for canine hemophilia B
- (2018) Jian Gao et al. Molecular Therapy-Nucleic Acids
- A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
- (2018) Ang Li et al. Molecular Therapy-Methods & Clinical Development
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10
- (2017) Guo-Xiang Ruan et al. MOLECULAR THERAPY
- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
- (2017) Brett T Staahl et al. NATURE BIOTECHNOLOGY
- Cell-Penetrating Peptides: From Basic Research to Clinics
- (2017) Giulia Guidotti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Genome editing abrogates angiogenesis in vivo
- (2017) Xionggao Huang et al. Nature Communications
- Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
- (2017) Niclas E. Bengtsson et al. Nature Communications
- Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice
- (2017) Wenhan Yu et al. Nature Communications
- Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
- (2017) Pavel I. Ortinski et al. Molecular Therapy-Methods & Clinical Development
- Engineering CRISPR–Cpf1 crRNAs and mRNAs to maximize genome editing efficiency
- (2017) Bin Li et al. Nature Biomedical Engineering
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- Lentivirus pre-packed with Cas9 protein for safer gene editing
- (2016) J G Choi et al. GENE THERAPY
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
- (2016) Shengdar Q. Tsai et al. NATURE REVIEWS GENETICS
- CRISPR/Cas9-mediated gene knockout in the mouse brain using in utero electroporation
- (2016) Yohei Shinmyo et al. Scientific Reports
- Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases
- (2016) Diane Yang et al. Scientific Reports
- Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases
- (2015) Kentaro Ishida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection
- (2015) Xiquan Liang et al. JOURNAL OF BIOTECHNOLOGY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- (2015) Takeshi Maruyama et al. NATURE BIOTECHNOLOGY
- A split-Cas9 architecture for inducible genome editing and transcription modulation
- (2015) Bernd Zetsche et al. NATURE BIOTECHNOLOGY
- Functional annotation of native enhancers with a Cas9–histone demethylase fusion
- (2015) Nicola A Kearns et al. NATURE METHODS
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- Development of an intein-mediated split–Cas9 system for gene therapy
- (2015) Dong-Jiunn Jeffery Truong et al. NUCLEIC ACIDS RESEARCH
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells
- (2014) W. Ding et al. CLINICAL CANCER RESEARCH
- Adenovirus: The First Effective In Vivo Gene Delivery Vector
- (2014) Ronald G. Crystal HUMAN GENE THERAPY
- TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
- (2014) Zheng Hu et al. JOURNAL OF CLINICAL INVESTIGATION
- Preclinical research: Make mouse studies work
- (2014) Steve Perrin NATURE
- Single nucleotide variations: Biological impact and theoretical interpretation
- (2014) Panagiotis Katsonis et al. PROTEIN SCIENCE
- Mechanisms of epigenetic memory
- (2014) Agustina D’Urso et al. TRENDS IN GENETICS
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
- (2014) R. Jude Samulski et al. Annual Review of Virology
- Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms
- (2013) I. Lentacker et al. ADVANCED DRUG DELIVERY REVIEWS
- An estimation of the number of cells in the human body
- (2013) Eva Bianconi et al. ANNALS OF HUMAN BIOLOGY
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer
- (2012) G. Buchlis et al. BLOOD
- Directed evolution of novel adeno-associated viruses for therapeutic gene delivery
- (2012) M A Bartel et al. GENE THERAPY
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
- (2011) Virginie Monteilhet et al. MOLECULAR THERAPY
- High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases
- (2011) Fuqiang Chen et al. NATURE METHODS
- AAV-mediated gene targeting methods for human cells
- (2011) Iram F Khan et al. Nature Protocols
- Regulation of Homologous Recombination in Eukaryotes
- (2010) Wolf-Dietrich Heyer et al. Annual Review of Genetics
- Distinct Epigenomic Landscapes of Pluripotent and Lineage-Committed Human Cells
- (2010) R. David Hawkins et al. Cell Stem Cell
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
- (2009) Frederic Heitz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Genome Size on AAV Vector Packaging
- (2009) Zhijian Wu et al. MOLECULAR THERAPY
- Epidemic Keratoconjunctivitis Due to the Novel Hexon-Chimeric-Intermediate 22,37/H8 Human Adenovirus
- (2008) K. Aoki et al. JOURNAL OF CLINICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search